Farum, Denmark

Dorte Strøbaek

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Dorte Strøbaek: Innovating Ion Channel Activating Agents

Introduction: Dorte Strøbaek, an accomplished inventor based in Farum, Denmark, has made significant contributions to the field of pharmaceuticals with her innovative research and development of ion channel activating agents. With a patented invention that focuses on isatin derivatives, Strøbaek's work offers promising avenues for treating a wide array of medical conditions.

Latest Patents: Dorte Strøbaek holds a notable patent titled "Use of isatin derivatives as ion channel activating agents." This patent specifically pertains to a unique class of chemical compounds that function as openers of SKCa and IKCa channels. Strøbaek's invention outlines the use of these agents for the manufacture of medicaments and pharmaceutical compositions that target various diseases linked to SK/IK channels, including respiratory conditions like asthma, cystic fibrosis, and chronic obstructive pulmonary disease, among many others.

Career Highlights: Strøbaek's career is marked by her role at Neurosearch A/S, where she collaborates on groundbreaking research within the pharmaceutical industry. Her commitment to innovation and scientific advancement has positioned her as a key figure in the development of new therapeutic agents, showcasing her expertise in the field.

Collaborations: Throughout her career, Dorte Strøbaek has had the pleasure of working alongside distinguished colleagues, including Bo Skaaning Jensen and Tino Dyhring Jørgensen. These collaborations have facilitated the exchange of ideas and further propelled the advancements in their collective research efforts.

Conclusion: Dorte Strøbaek's inventive journey exemplifies the power of innovation in addressing complex medical challenges. Her patent on isatin derivatives as ion channel activating agents has the potential to revolutionize treatments for a multitude of diseases. As she continues her work at Neurosearch A/S, her contributions will undoubtedly leave a lasting impact in the realm of pharmaceuticals and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…